Scott W. Morrison - Oct 6, 2022 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Director
Signature
/s/ Leonard M. Greenstein, Attorney-in-Fact
Stock symbol
TARS
Transactions as of
Oct 6, 2022
Transactions value $
$0
Form type
4
Date filed
10/11/2022, 04:23 PM
Previous filing
Oct 6, 2022
Next filing
May 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TARS Employee Stock Option (right to buy) Award $0 +14K $0.00 14K Oct 6, 2022 Common Stock 14K $17.21 Direct F1
transaction TARS Restricted Stock Units Award $0 +4K $0.00 4K Oct 6, 2022 Common Stock 4K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares vest in three equal annual installments beginning on October 6, 2023, subject to the Reporting Person's continuous service.
F2 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
F3 The RSUs will vest in three equal annual installments on September 15th of each of 2023, 2024, and 2025, subject to the Reporting Person's continuous service.